Idéal Investisseur
Français English
CAC 40 : Market open
8 209,68 pts
+0.64%


Last updated : 27/04/2026 - 13h37
🏠 Home   ➤    Stock news

HCA Healthcare Stock Rises 3.09% at Close

HCA Healthcare's stock advanced by 3.09% on Friday, November 21, closing at $491.00. This spike is part of a broader trend that has seen the stock significantly outperform the market since the beginning of the year. The rise reflects a sustained momentum in the hospital sector.


HCA Healthcare Stock Rises 3.09% at Close

Closing Performance Details

The stock closed at $491.00, up 3.09% from the previous session ($476.28). During the November 21 session, the stock ranged between $477.00 and $493.80, with the intraday high reflecting strong buyer demand. A total of 1.935 million shares were traded, representing 0.85% of HCA Healthcare's total market capitalization ($112.04 billion). This trading intensity illustrates sustained interest in this hospital sector giant. On a weekly basis, the stock has accumulated gains of 3.88%, confirming a steady upward trend. Over twelve months, the gain reaches 47.78%, significantly outperforming the S&P 500's increase of 18.33%. From its 52-week low of $289.98, the stock has risen by approximately 70%. On Friday, the S&P 500 rose by only 0.36%, leaving HCA Healthcare well ahead in the session.

Company Overview and Market Position

Free · Every morning
Technical market signals, before the opening bell.
Bullish and bearish momentum, analyst changes, stocks to watch — automatically computed from Euronext data.
Before 9 AM every morning Euronext data AI-powered analysis

HCA Healthcare remains a major player in the American hospital sector, benefiting from stable demand for medical services and a dense network of facilities across the country. The group continues to generate steady results in an environment characterized by persistent margin pressures, notably due to labor cost developments and reimbursement rate pressures. The hospital sector faces structural challenges, but HCA Healthcare strives to maintain healthy operational margins and generate regular cash flows. Wall Street analysts closely monitor the group's activity indicators, including patient volumes and operational efficiency. The stock's performance in 2025 suggests that markets anticipate a continuation of operational stability. This favorable perception has translated into sustained trading and a steadily rising stock price. Confidence in this stock is based on the group's market position and its ability to navigate a challenging context while maintaining profitability.

Related




Assurance vie
Advertisement
Every morning
Technical market signals,
before the opening bell.
CAC 40 · SBF 120 · Signals · Analysts
🤖
Today's edition — pre-market
CAC 40
7 702
-0,87%
SBF 120
5 827
-0,87%
📈 Bullish signals
+5,2%
+1,8%
+0,9%
📉 Bearish signals
-14%
-5,7%
🔄 Analyst opinions
▲ 35 €
▼ 80 €
Sign up to see everything →
Before 9 AM every morning
Euronext data
AI-powered analysis





BOURSE · Chaque matin
La synthèse bourse,
avant l'ouverture.
Notre moteur analyse chaque nuit le CAC 40 et le SBF 120. Ce qui mérite attention remonte directement dans votre boîte mail. Gratuit.
Avant 9h00 1000+ inscrits 100% gratuit